Ranbaxy Laboratories
Plot 90, Sector 32
Gurgaon, Haryana
(L) +91-124-4135000, (F) +91-124-4135001
Website
Company Profile
About Ranbaxy Laboratories
Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company’s foray into Novel Drug Delivery Systems has led to proprietary "platform technologies", resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 9 countries.
For more information, visit www.ranbaxy.com.
Contact Person(s)
Ranbaxy Laboratories recent press release(s)
The deal is valued at R500 million (USD 70 Million) and will make Ranbaxy the fifth largest generic pharmaceutical company in South Africa. More...
Ranbaxy Q1 2007 Net Profit Rises 79% to Rs.129 CroresOperating profit before tax doubles (Rs 1,597 Mn, up 100%); Consolidated Revenues at Rs.15,644 Mn; up 23% compared to corresponding quarter. More...
Ranbaxy receives us FDA approval to manufacture and market Pravastatin Sodium Tablets in USARanbaxy granted 180 days exclusivity for 80mg dosage More...
Terapia Ranbaxy receives GMP Certificate renewal from National Agency of Medicine for Bucharest SiteFollowing an inspection conducted by the National Agency of Medicine, the Bucharest based production facility of Terapia Ranbaxy has received a renewal of certification for Good Manufacturing Practice standards at the operational level. More...
Ranbaxy annual audited results for year 2006; Net Profit up 95% at Rs.5,154 MN; Global sales at Rs.60,652 MN, + 17% growthBoard approves 2nd interim dividend of 120% taking total dividend for 2006 to 170% More...